NVAX — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Novavax, Inc.
Healthcare · $9.49
1.0
/10
Poor Entry
↓ -1.0 today
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bullish
vs SMA200
SMA200 Distance
+12.8%
Above trend
Volatility
Normal
Average premiums
Momentum
Decelerating
2nd day
About Novavax, Inc.
Novavax is a biotech focused on protein-based COVID and flu vaccines. Highly volatile and speculative, driven by regulatory decisions, partnership news, and revenue uncertainty. No dividend. CSP premiums are rich from sky-high IV, but binary event risk is severe — suitable only for aggressive, event-aware sellers comfortable with large gaps.
Biotechnology
Market Cap
$1.6B
P/E Ratio
Beta
2.41
Forward P/E
-17.5
52-Week Range Current: $9.49
$6.13 $11.97
Earnings
2026-08-05
60 days away

NVAX — the read reflects breadth across multiple soft dimensions rather than a single broken signal. No single factor explains the score; the composite does.

Based on end-of-day market dataScored by ThetaLoop Research
NVAX ranks #22 of 66 Healthcare tickers by put-selling score (622 total screened)

Position Size & Yield Calculator

Live model for NVAX — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
GILD Gilead Sciences, Inc. 6.7 BMY Bristol-Myers Squibb Company 6.2 REGN Regeneron Pharmaceuticals, Inc. 6.1 PFE Pfizer Inc. 6.0 BHC Bausch Health Companies Inc. 4.7 Browse all Healthcare tickers →
📌 Embed this score on your blog
The NVAX X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/NVAX" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/NVAX">NVAX X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Full Research Track Record — All Wins AND Losses
Cash-Secured Puts ↗ · Bull Put Spreads ↗ · See a sample →